Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical Neuropsychiatry|January 11, 2023
The Relationship Between Covid-19 Risk Perception and Vaccine Hesitancy in Cancer Patients: The Moderating Role of Externalizing TraitsSimone Cheli, Maria Simona Pino, Gil Goldzweig, et al.
Italian Journal of Dermatology and Venereology|June 15, 2019
Melanoma diagnosis: traumatic impact of the event on the patientEleonora Campolmi, Margherita Riccio, Bernardo Carli, et al.
BMJ Open|July 2, 2018
Conflict of interest among Italian medical oncologists: a national surveyAndrea DeCensi, Gianmauro Numico, Enzo Ballatori, et al.
Anti-Cancer Drugs|August 5, 2015
A retrospective analysis of trabectedin infusion by peripherally inserted central venous catheters: a multicentric Italian experienceFrancesca Martella, Vanda Salutari, Claudia Marchetti, et al.
Recenti Progressi in Medicina|May 6, 2024
[What patients with cancer think about the dehospitalization. A survey of Cipomo.]Sandro Barni, Carlo Aschele, Livio Blasi, et al.
Recenti Progressi in Medicina|August 28, 2025
Quality of life among retired oncologists and their willingness to serve: a nationwide representative surveySandro Barni, Luigi Cavanna, Paolo Tralongo, et al.
European Journal of Cancer (Oxford, England : 1990)|April 21, 2020
Reorganisation of medical oncology departments during the novel coronavirus disease-19 pandemic: a nationwide Italian surveyAlice Indini, Carlo Aschele, Luigi Cavanna, et al.
Psycho-Oncology|July 27, 2021
Risk perception, treatment adherence, and personality during COVID-19 pandemic: An international study on cancer patientsSimone Cheli, Wendy W T Lam, Tania Estapé, et al.
Frontiers in Oncology|February 27, 2023
Neoadjuvant plus adjuvant combined or sequenced vemurafenib, cobimetinib and atezolizumab in patients with high-risk, resectable BRAF-mutated and wild-type melanoma: NEO-TIM, a phase II randomized non-comparative studyPaolo A Ascierto, Eleonora Cioli, Vanna Chiarion-Sileni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2007
Phase III trial of infusional fluorouracil, leucovorin, oxaliplatin, and irinotecan (FOLFOXIRI) compared with infusional fluorouracil, leucovorin, and irinotecan (FOLFIRI) as first-line treatment for metastatic colorectal cancer: the Gruppo Oncologico Nord OvestAlfredo Falcone, Sergio Ricci, Isa Brunetti, et al.
Pageof 3